Covaxin’s Phase 3 trial data which has shown 77.8% efficacy was approved by the Subject Expert Committee (SEC) under DCGI on Tuesday.
Bharat Biotech’s Covaxin Shows 77.8% Efficacy in Phase 3 Trial Data
Similar Articles
Lakhimpur Kheri: Viral Video Shows Farmers Being Run Over by SUV, Oppn Questions Union Minister’s Claims
The 29-second clip, which also shows another vehicle following the SUV, has raised questions on the version of the incident by Union minister Ajay...
Karnataka: 3 Dead After Drinking Contaminated Water, 108 Show Similar Symptoms
A total of six people have died in the last five weeks but the authorities have been able link just three of the deaths...